Clinical Trial Update: Target Site Pharmacokinetics of Ertapenem After Multiple Doses in Diabetes Patients With Soft Tissue Infection [Phase 4]

View source ↗

Summary

Phase 4 study update on the site pharmacokinetics of ertapenem after multiple doses in diabetes patients with soft tissue infection; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Infection

Drugs mentioned

• Invanz (ertapenem) (ertapenem)

Snippet

Sponsor: Medical University of Vienna | Conditions: Soft Tissue Infection | Phase 4 | Status: COMPLETED